Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-14T15:23:04.133Z Has data issue: false hasContentIssue false

176 - Hormone Replacement Therapy

from Section 3 - Treatment and Care

Published online by Cambridge University Press:  05 June 2019

By
Martha Hickey  and
Annabelle Brennan
Edited by
Carrie D. Llewellyn ,
Susan Ayers ,
Chris McManus ,
Stanton Newman ,
Keith J. Petrie ,
Tracey A. Revenson  and
John Weinman
Carrie D. Llewellyn
Affiliation:
University of Sussex
Susan Ayers
Affiliation:
City, University of London
Chris McManus
Affiliation:
University College London
Stanton Newman
Affiliation:
City, University of London
Keith J. Petrie
Affiliation:
University of Auckland
Tracey A. Revenson
Affiliation:
City University of New York
John Weinman
Affiliation:
King's College London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Cambridge Handbook of Psychology, Health and Medicine , pp. 633 - 635
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andreen, L., Nyberg, S., Turkmen, S., et al. (2009). Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology, 34, 1121–1132.Google Scholar
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., et al. (2005). Menopausal symptoms and treatment related effects of estrogen and progestin in the women’s health initiative. Obstetrics and Gynaecology, 105, 1063–1073.Google Scholar
Beral, V., et al., Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362, 419–427.Google Scholar
Bergandal, A., Kieler, H., Sundstrom, A., et al. (2016). Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Menopause, 23(6), 593–599.CrossRefGoogle Scholar
Canonico, M., Oger, E., Plu-Bureau, G., et al. (2007). Hormone therapy and venous thromboembolism among postmenopausal women. Circulation, 115, 840–845.Google Scholar
Cauley, J. A., Robbins, J., Chen, Z., et al. (2003). Effects of estrogen plus progestin on risk of fracture and bone mineral density; the women’s health initiative randomized trial. Journal of the American Medical Association, 290, 1729–1738.CrossRefGoogle ScholarPubMed
Cohen, L. S., Soares, C. N., Vitonis, A. F., et al. (2006). Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of General Psychiatry, 63(4), 385–390.CrossRefGoogle Scholar
Cushman, M., Kuller, L. H., Prentice, R., et al. (2004). Estrogen plus progestin and risk of venous thrombosis. Journal of the American Medical Association, 292, 1573–1580.CrossRefGoogle ScholarPubMed
Deecher, D., Andree, T. H., Sloan, D., et al. (2008). From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology, 33(1), 3–17.Google Scholar
Fahlen, M., Fornander, T., Johansson, H., et al. (2013). Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. European Journal of Cancer, 49, 52–59.Google Scholar
Freeman, E. W., Sammel, M. D., Lin, H., et al. (2006). Association of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63(4), 375–382.Google Scholar
Furness, S., Roberts, H., Marjoribanks, J., et al. (2012). Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database of Systematic Reviews, 8, CD000402.Google Scholar
Gold, E. B., Colvin, A., Avis, N., et al. (2006). Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. American Journal of Public Health, 96(7), 1226–1235.Google Scholar
Hoga, L., Radolpho, J., Goncalves, B., et al. (2015). Women’s experience of menopause: a systematic review of qualitative evidence. JBI Database of Systematic Reviews and Implementation Reports, 13(8), 250–337.CrossRefGoogle ScholarPubMed
Holmberg, L., Iverson, O. E., Rudenstam, C. M., et al. (2008). Increased risk of recurrence after hormone replacement therapy in breast cancer survivor. Journal of the National Cancer Institute, 100, 475–482.CrossRefGoogle Scholar
Leidy, S. (2013). Menopause across cultures: clinical considerations. North American Menopause Society practice pearl. Menopause, 21(4), 421–423.Google Scholar
MacLennan, A. H., Boradbent, J. L., Lester, S., et al. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Systematic Reviews, 18(4), CD002978.Google Scholar
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., et al. (2013). Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. Journal of the American Medical Association, 310(13), 1353–1368.Google Scholar
Melby, M. K., Lock, M., Kaufert, P., et al. (2005). Culture and symptom reporting at menopause. Human Reproduction Update, 11(5), 495–512.Google Scholar
Mohammed, K., Abu Dabrh, A. M., Benkhadra, K., et al. (2015). Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism, 100(11), 4012–4020.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. (2015). Menopause: diagnosis and management guideline. National Institute for Health and Care Excellence, 8, 1–29.Google Scholar
Neves-e-Castro, M., Birkhauser, M., Samsioe, G., et al. (2015). EMAS Position Statement: the ten point guide to the integral management of menopausal health. Maturitas, 81, 88–92.CrossRefGoogle Scholar
North American Menopause Society. (2012). The 2012 hormone therapy position statement of the North American Menopause Society. Menopause, 19(3), 257–271.CrossRefGoogle Scholar
Obermeyer, C. M. (2000). Menopause across cultures: a review of the evidence. Menopause, 7(3), 184–192.CrossRefGoogle ScholarPubMed
Roberts, H. & Hickey, M. (2015). Should hormone therapy be recommended for prevention of cardiovascular disease? Cochrane Database of Systematic Reviews, 3, ED000097.Google Scholar
Schenck-Gustafsson, K., Brincat, M., Gambacciani, M., et al. (2011). EMAS position statement: managing the menopause in the context of coronary heart disease. Maturitas, 68(1), 94–97.Google Scholar
Schmidt, P. J. & Rubinow, D. R. (2009). Sex hormones and mood in the perimenopause. Annals of the New York Academy of Sciences, 1179, 70–85.CrossRefGoogle ScholarPubMed
Schmidt, P. J., Ben Dor, R., Martinez, P. E., et al. (2015). Effects of estradiol withdrawal on mood in women with past perimenopausal depression. JAMA Psychiatry, 72(7), 714–726.CrossRefGoogle ScholarPubMed
Stuenkel, C. A., Davis, S. R., Gompel, A., et al. (2015). Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 100(11), 3975–4011.CrossRefGoogle ScholarPubMed
Suckling, J. A., Lethaby, A., Kennedy, R. (2006). Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews, 4, CD001500.Google Scholar
Timur, S. & Sahin, N. H. (2010). The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause, 17(3), 545–551.Google Scholar
Worsely, R., Davis, S. R., Gavrilidis, E., et al. (2012). Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas, 73, 127–133.CrossRefGoogle Scholar
Worsley, R., Bell, R., Kulkarni, J., et al. (2014). The association between vasomotor symptoms and depression during perimenopause: a systematic review. Maturitas, 77, 111–117.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×